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How hibernation and hypothermia help to improve
anticoagulant control
Edwin L de Vrij* and Robert H Henning
Department of Clinical Pharmacy and Pharmacology; University Medical Center Groningen; University of Groningen; Groningen, The Netherlands
Winter is coming. Some animalssuccessfully cope with the hostility
of this season by hibernating. But how do
hibernators survive the procoagulant
state of months of immobility at very
low body temperatures, with strongly
decreased blood flow and increased blood
viscosity? Changing the coagulation sys-
tem seems crucial for preventing throm-
boembolic complications.
Once disclosed, the adaptive mecha-
nisms in the coagulation system of hiber-
nators may be hijacked to prevent
thromboembolism in non-hibernators
including humans. The mechanisms dem-
onstrate a large overlap with the effects of
cooling (in non-hibernators). Studying
coagulation in natural hibernation and in
suspended animation in non-hibernators,
may unveil ways to enable cold storage of
platelets for transfusion, improve the
use of therapeutic hypothermia and opti-
mize anticoagulative strategies during
immobility.
While drastic changes in many physio-
logical systems have been reported in
hibernators, our recent study explored the
rapid adaptations in the coagulation sys-
tem.1 Key to hibernation is the dramatic
drop in metabolic rate–and subsequent
reduction of body temperature–to save
energy. During hibernation, phases with
metabolic suppression (called torpor) are
interspersed by shorter periods of arousal,
when metabolism and body temperature
restore to normal. Deep hibernation typi-
cally features torpor phases of 4–14 d and
arousals lasting up to 1 day. Alternatively,
depending on ambient temperature and
animal size, daily hibernation with torpor
phases lasting a couple of hours may be
energetically more favorable. In addition
to natural hibernation, ‘hibernation’ may
be induced by the administration of com-
pounds inducing reversible metabolic
suppression. The research of this pharma-
cologically induced ‘hibernation’ was
boosted by the discovery that H2S revers-
ibly suppresses metabolism inducing a
state of suspended animation2 and further
stimulated by the discovery of the action
of 50-AMP (50-adenosine monophos-
phate) in torpid (hibernating) mice.3
Given the full preservation of organ
structure and function, mechanisms of
hibernation (and perhaps also of sus-
pended animation) may be beneficial in
the medical setting to protect cellular and
organ function, thus improving therapeu-
tic hypothermia in pediatric and adult
patient care, organ transplantation, car-
diopulmonary bypass, stroke, cancer
radiotherapy, cardiac arrest, hemorrhagic
shock and malignant fever. It is however
quite uncertain that hibernation may be
induced in humans, as it presumably
requires additional adaptations in physiol-
ogy beyond metabolic suppression.
Unraveling the mechanisms of such addi-
tional adaptations in hibernation seems
warranted to fully exploit opportunities in
the medical setting.
The coagulation system is bound to
undergo major changes during hiberna-
tion. According to Virchow’s postulates,
hibernation represents a procoagulant
state due to the prolonged immobility,
decreased heart and ventilation rate, low
blood flow, increased blood viscosity and
repetitive cycles of cooling and rewarm-
ing (i.e. from 37C to 8C). Despite this
gloomy prospect, no signs of thrombo-
embolism are detected in hibernators. In
contrast, in a human bedridden patient,
such a dire situation surely leads to
potential lethal complications including
venous thrombosis and pulmonary
embolism (Fig. 1). One of the key adap-
tations in the coagulation system of
hibernators is a fully reversible state of
thrombocytopenia (low blood platelet
count).1 Platelets form along with coagu-
lation factors the primary respectively
secondary pathway of the coagulation
system. Balancing the coagulant state
depends on blood constituents, the vessel
wall and endothelial integrity, and hemo-
dynamic stability.
To disclose how hibernating mam-
mals survive their procoagulant hiberna-
tion period, we analyzed their platelets.
We reveal that during torpor almost all
platelets (96%) disappear from the
hamster’s circulation. However, the
function of the few circulating platelets
seems fully preserved, as measured by
in vitro platelet activatibility. Remark-
ably, upon arousal, platelets are rapidly
reintroduced in the circulation to nor-
mal levels. This swift recovery of plate-
let counts upon arousal advocates a
storage-and-release mechanism rather
than de novo synthesis.
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Figure 1. Following Virchow’s triad, animals in hibernation are at high risk of thromboembolism and subsequent organ injury, similar to hospitalized
humans, subjected to a period of prolonged immobility. Consequently, bedridden patients sooner or later develop thrombosis and embolism with organ
injury, whereas hibernating mammals (such as the hamster) do not. Unraveling why they do not suffer thromboembolism, we show that during the
repetitive phases of torpor there is a reversible decrease (by 96%) in circulating platelet count (thrombocytopenia). The thrombocytopenia is likely due
to margination of platelets to the vessel wall, as depicted in the blood vessel during torpor, which rapidly reverses upon phases of arousal. Similarly, but
to a lesser extent, thrombocytopenia can be induced in a non-hibernating mammal by forced hypothermia, also this low platelet count is reversible
upon rewarming. Disclosing the shared underlying mechanism in hibernating and non-hibernating species can help us improve anticoagulant control
for humans at risk of thromboembolism and organ injury.
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Reversible clearance of platelets could
either be due to sequestration in the
spleen, or reversible adherence to vessels
by means of margination. Employing sple-
nectomy before or during torpor, we dem-
onstrated that the spleen neither serves an
essential role in induction nor in recovery
of thrombocytopenia during hibernation.
Hence, margination of platelets seems the
prevalent mechanism to deplete circulat-
ing platelets. However, it is unclear
whether margination during torpor is
induced by the mechanism causing hiber-
nation, or induced indirectly, e.g. by low-
ering of body temperature. Previously,
employing forced cooling of hamster, we
demonstrated that the decrease in circulat-
ing lymphocytes in torpor is solely driven
by storage in response to the lowering of
body temperature, inducing a drop in
plasma levels of shingosine-1-phosphate.4
The situation seems similar for platelets
(albeit independent of sphingosine-1-
phosphate). Forced cooling of hamster to
8C induced thrombocytopenia, which is
rapidly reversible upon rewarming. In
addition, forced cooling of mouse (which
may display daily hibernation upon food
restriction) and rat (a non-hibernator)
show a decrease in platelet count, generat-
ing a decrease of 28% at 20C and 35% at
15C, respectively, which was reversed
upon rewarming.1 However, 50-AMP
hypothermia decreased circulating lym-
phocyte but not platelet count. As 50-
AMP decreases platelet function, it is
conceivable that patent platelet function,
as found during torpor and forced hypo-
thermia, is relevant for low body tempera-
ture induced thrombocytopenia.
Our study hints at a shared mecha-
nism between non-hibernating and
hibernating mammals depending on low
body temperature induced reversible
hypocoagulability consisting of storage
of functional platelets, most likely by
margination.
Modulating platelet function by stor-
age seems an apt strategy in hibernation,
as platelets play a key role in blood clot-
ting. In addition, platelets mediate a.o.
the immune system, wound healing, tissue
repair and angiogenesis. Hence platelets
are thought to be involved in a myriad of
diseases, in which their role ranges from
hero to villain. Therefore, the body tem-
perature dependent storage of platelets
induces a hypocoagulability during the
potential hypercoagulant state of torpor
and aids in preventing organ injury, ensur-
ing full revitalization upon arousal. Thus,
surviving the hostile winter through hiber-
nation does not only depend on mecha-
nisms lowering metabolism, but also on
physiological adaptations rooted in lower-
ing of body temperature.
Apparently representing a common
phenomenon across species,1,5,6 hypother-
mia-induced thrombocytopenia may be
exploited to reversibly inhibit hemostatic
function and/or to prevent organ injury.
Particularly, cooling during suspended
animation may additionally invoke sus-
pended coagulation, which may alleviate
thromboembolic complications and organ
(ischemia/reperfusion) injury, e.g. in major
surgery and organ transplantation. More-
over, platelets from hibernators withstand
cold storage ex vivo and can readily be
infused without aggregation.5 Further
insight into the mechanism preventing
platelet function change and aggregation
by the cold may enable cold storage of pla-
telets for transfusion, improving logistics,
shelf life and eliminating the risk of bacte-
rial contamination during preservation at
room temperature.
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